Answer
Retsevmo (selpercatinib) is not recommended during pregnancy and should only be used if the potential benefit justifies the potential risk to the foetus.
Sources for this answer
- Retsevmo 40mg and 80mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked